Sign in

Private company

Biosplice Therapeutics

American biopharmaceutical company

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California.2 It was founded by Osman Kibar.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2008Founded1

See how the biggest companies compare on our leaderboards

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California.2

The story

Founded by Osman Kibar in 2008.1

Leadership

Who has led Biosplice Therapeutics, and when. Pick a name to see everywhere that person has worked.

Timeline

  1. 2008Founded Founded1

Calendar

Drug trials and FDA: recently

  1. Feb 20, 2024Phase 3 trial completed Phase 3 trial of Lorecivivint in Knee Osteoarthritis: primary completion Feb 20, 2024, results posted Sep 1, 2026 (ClinicalTrials.gov NCT05603754).3

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3